傳藝科技(002866.SZ):擬設全資子公司重慶傳藝科技
格隆匯6月4日丨傳藝科技(002866.SZ)公佈,公司於2021年6月4日召開第三屆董事會第六次會議,審議通過了《關於對外投資設立全資子公司的議案》,擬以自有資金設立全資子公司“重慶傳藝科技有限公司”(“重慶傳藝”,最終名稱以工商註冊登記為準),註冊資本1億元人民幣,公司持有其100%股份。
此次投資設立全資子公司是公司基於戰略整體佈局及未來發展需要、立足於長遠利益所作出的審慎決策,設立全資子公司能有利於進一步推動公司的業務發展,完善公司產業佈局,充分利用好各地產業扶持政策,促進公司發展戰略的落地實施,不斷提升公司綜合實力,助力公司持續健康、高質量發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.